Opportunity ID: 342809

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-22-022
Funding Opportunity Title: Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 28, 2022
Last Updated Date: Jul 28, 2022
Original Closing Date for Applications: Feb 21, 2023
Current Closing Date for Applications: Feb 21, 2023
Archive Date: Mar 29, 2023
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Independent school districts
City or township governments
State governments
Private institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity will support multi-disciplinary teams to examine interactions between exocrine and endocrine pancreas to support the study of T1D. The purpose of this opportunity is to encourage integrated study of the whole pancreas to enable characterization of direct and indirect crosstalk between exocrine and endocrine compartments, and identification of the mechanisms by which that crosstalk occurs and can be disrupted in T1D and other forms of diabetes. Development of assays or platforms to allow for broader investigation into these questions could also be supported.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-022.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 342809 Full Announcement-RFA-DK-22-022 -> RFA-DK-22-022-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00276201 Jan 21, 2023 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277866 Jan 21, 2023 Feb 21, 2023 View

Package 1

Mandatory forms

342809 RR_SF424_5_0-5.0.pdf

342809 PHS398_CoverPageSupplement_5_0-5.0.pdf

342809 RR_OtherProjectInfo_1_4-1.4.pdf

342809 PerformanceSite_4_0-4.0.pdf

342809 RR_KeyPersonExpanded_4_0-4.0.pdf

342809 PHS398_ResearchPlan_4_0-4.0.pdf

342809 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342809 RR_Budget_3_0-3.0.pdf

342809 RR_SubawardBudget30_3_0-3.0.pdf

342809 PHS398_ModularBudget_1_2-1.2.pdf

342809 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

342809 RR_SF424_5_0-5.0.pdf

342809 PHS398_CoverPageSupplement_5_0-5.0.pdf

342809 RR_OtherProjectInfo_1_4-1.4.pdf

342809 PerformanceSite_4_0-4.0.pdf

342809 RR_KeyPersonExpanded_4_0-4.0.pdf

342809 PHS398_ResearchPlan_5_0-5.0.pdf

342809 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342809 RR_Budget_3_0-3.0.pdf

342809 RR_SubawardBudget30_3_0-3.0.pdf

342809 PHS398_ModularBudget_1_2-1.2.pdf

342809 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T13:36:36-05:00

Share This Post, Choose Your Platform!

About the Author: